Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-253-7
CAS number: 104-93-8
Acute oral toxicity was assessed in two studies similar to OECD test guideline 401, resulting in a LD50 of 1920 mg/kg body weight in rats and an LD50 between 1940 and 4850 mg/kg body weight in mice.In the key study for acute inhalative toxicity according to OECD test guideline 403 in rats, the LD50 was determined to be > 6.1 mg/l after a treatment period of 4 hours. Acute dermal toxicity was assessed in a study similar to OECD test guideline 402, resulting in a LD50 > 4850 mg/kg body weight.
Acute oral toxicity.
In the key study, similar to OECD test guideline 401, acute oral
toxicity of 4-methylanisole was assessed in six groups of 5
Sprague-Dawley rats. Rats were treated with a single oral dose in corn
oil via gavage at dose levels ranging from 1000-6810 mg/kg body weight
(not further specified). Under the conditions of this study, LD50 was
found to be 1920 mg/kg body weight for rats (RIFM1971).
In the supportive study, similar to OECD test guideline 401, 10 fasted
mice were treated with a single oral dose of unchanged 4-methylanisole
via gavage at dose levels of 2 ml/kg bw (2 animals), 5 ml/kg bw (6
animals), 10 ml/kg bw (2 animals) and observed over a period of 7 days
for signs of toxicity. Under the conditions of this study, LD50 was
defined to be between 2 and 5 ml/kg bw for mice, representing 1940 and
4850 mg/kg bw respectively, (Givaundan MT1971).
Acute inhalative toxicity.
In the key study for acute inhalative toxicity according to OECD test
guideline 403, 5 Wistar rats per sex were treated in a whole-body
inhalation system using 4-methylanisole at the maximum technically
achievable concentration (6.1 mg/l) for 4 hours followed by an
observation period of 14 days (BASF13I0143/897023). No
mortality occurred during the study period. Accelerated, irregular or
intermittent respiration, eyelid closure, salivation, abdominal
position, squatting posture, ruffled fur and tremor was observed during
treatment, followed by additional findings, i.e. reddish nasal discharge
and urine-contaminated fur. A retardation of the body weight gain was
detected after the second week of the observation period in comparison
to historical control data. No pathologic findings were noted. The LC50
was determined to be > 6.1 mg/l air after a 4 hour exposure.
In the supportive study, an inhalation hazard test similar to OECD test
guideline 403, 3 Wistar rats per sex were exposed whole body with a
4-methylanisole vapour saturated atmosphere (6.71 mg/l nominal
concentration, not verified analytically) for 7 hours followed by an
observation period for 14 days (BASF10I0143/897007). No mortality was
observed during the observation period. During exposure, irregular or
accelerated respiration and nasal discharge was observed, whereas no
abnormalities became evident after the exposure period. No pathologic
findings during necropsy were observed. The LC50 was determined to be >
6.71 mg/l air after a 7 hour exposure.
Acute dermal toxicity.
In the key study addressing acute dermal toxicity similar to OECD test
guideline 402, 6 New Zealand White rabbits were treated dermally (under
occlusion) with 5 ml/kg bw (4850 mg/kg bw respectitvely) 4-methylanisole
and followed by an observation period of 14 days (RIFM 1971). No
mortality was observed, resulting in an LD50 > 5 ml/kg bw.
Based on the available data, 4-methylanisole is to be classified as
harmful if swallowed (R22) and as acute toxic / oral (Category 4)
according to the criteria laid down under 67/548/EEC and regulation (EU)
The present data on acute inhalative and dermal toxicity do not fulfill
the criteria laid down in 67/548/EEC and regulation (EU) 1272/2008, and
therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again